Aarey Drugs & Pharmaceuticals logo

Aarey Drugs & Pharmaceuticals financials and balance sheet

NSE: AAREYDRUGSBSE: 524412Pharmaceuticals & BiotechnologySmall Cap

Last close ₹106.73down ₹3.68 (3.33%)BSE ₹105.95

Share price at the NSE close on 23 Oct 2026. Previous close ₹110.41.

52-week range of traded prices to 23 Oct 2026
₹50.31Low, 30 Mar 2026₹114.80High, 19 Oct 2026
Market cap
₹340 Cr2,366th largest listed
P/E
Earlier quarters restated in the year
P/B
Shares changed
Dividend yield
Nonein the last 12 months
ROCE
1.8%
Debt to equity
0.33
Volume, NSE
2,92,24274.3% delivered

10 years at a glance

Standalone: the listed company alone, without its subsidiaries. ₹ crore, years to March.Aarey Drugs & Pharmaceuticals annual reports

Revenue, net profit and borrowings, ₹ crore

  • Revenue
  • Net profit
  • Borrowings

Operating and net margin, per cent

  • Operating margin
  • Net margin

The years either side of a change of basis do not compare. From the year to Mar 2021, the company's revenue for that year, ₹348 Cr, differs from its quarters added, ₹333 Cr.

Results for the year to Mar 2026

Standalone: the listed company alone, without its subsidiaries. ₹ crore.

From revenue to net profit

  1. Revenue472
  2. Materials and goods−455
  3. Employee costs−0.8
  4. Other expenses−9.8
  5. Operating profit7.2
  6. Depreciation−2.9
  7. Other income+6.1
  8. One-off items0.0
  9. Finance costs−5.0
  10. Profit before tax5.4
  11. Tax−1.4
  12. Net profit4.0

What the company owns

  • Receivables₹130 Cr
  • Plant, investments and other assets₹125 Cr
  • Inventory₹42 Cr
  • Cash and bank₹1 Cr

What pays for it: net worth and liabilities

  • Net worth₹150 Cr
  • Owed to suppliers₹82 Cr
  • Borrowings₹50 Cr
  • Other liabilities₹15 Cr

Profit and loss

Standalone, ₹ crore, years to March. No results on record for the year to Mar 2023.Aarey Drugs & Pharmaceuticals quarterly results

₹ croreMar 2017Mar 2018Mar 2019Mar 2020Filed 11 AugMar 2021Filed 6 JulMar 2022Filed 28 JunMar 2023Mar 2024Filed 9 JulMar 2025Filed 2 AugMar 2026Filed 30 May
Revenue from operations396349355300348493–396474472
386342347297344481–391471465
Materials and goods bought–337341290338467–382462455
Employee costs–––005–111
Other expenses–––769–9810
Operating profit before depreciation10883511–437
Operating margin2.4%2.2%2.2%1.1%1.3%2.3%–1.1%0.6%1.5%
Materials, % of revenue–––96.7%97.0%94.8%–96.5%97.5%96.2%
Employee costs, % of revenue–––0.0%0.1%1.0%–0.2%0.2%0.2%
Other expenses, % of revenue–––2.2%1.6%1.9%–2.2%1.7%2.1%
Depreciation and amortisation111112–223
Operating profit after depreciation977249–314
Other income334773–7106
Finance costs422222–455
One-off items–––000–000
Profit before tax8897810–565
222122–121
Net profit667678–544
Net margin1.5%1.8%1.8%1.9%1.9%1.5%–1.2%0.8%0.8%
Materials, employee costs and other expenses are shown for the years they add up to operating expenses; for the years to Mar 2017, Mar 2018 and Mar 2019 they do not, so they are left blank.

Balance sheet

Standalone, ₹ crore, at 31 March.

₹ croreMar 2020Filed 11 AugMar 2021Filed 6 JulMar 2022Filed 28 JunMar 2023Mar 2024Filed 9 JulMar 2025Filed 2 AugMar 2026Filed 30 May
92–114–133138150
Share capital23–25–282828
Reserves69–88–105110122
18–14–313550
100–20–168149145
1–111–432
Total assets194–245–305291297
13–37–2072534
181–208–98266263
Net debt17–14–303349
Borrowings are counted again inside the liabilities due within a year and after a year. No balance sheet is on record for the years to Mar 2017, Mar 2018, Mar 2019 and Mar 2021, so its lines and the ratios worked from it are blank there.

Cash flow

Standalone, ₹ crore, years to March.

₹ croreMar 2021Filed 6 JulMar 2022Filed 28 JunMar 2023Mar 2024Filed 9 JulMar 2025Filed 2 AugMar 2026Filed 30 May
8.318.6–7.910.310.1
8.322.2–7.212.211.7
–10.2–0.2−0.6−26.8
Receivables–25.7–5.351.03.8
Inventories–4.8–−5.9−10.83.9
Payables–−0.7–1.6−26.4−21.0
Other working capital–−19.7–−0.9−14.3−13.6
Tax paid–−3.6–0.7−1.9−1.6
Capital spending–2.2–0.05.212.4
Free cash flow8.316.4–7.95.1−2.3
–24.4–−7.3−5.9−12.4
–4.4–4.1−4.52.2
Dividends paid–0.0–0.00.00.0
Shares bought back–0.0–0.00.00.0
Shares issued–8.2–––0.0
Net change in cash8.347.3–4.7−0.1−0.1
Capital spending is part of cash from investing, and dividends paid, shares bought back and shares issued are part of cash from financing. Each is shown as an amount on a line of its own, and the section's other items are in its total only. No cash flow statement is on record for the years to Mar 2017, Mar 2018, Mar 2019 and Mar 2020. Shares issued is left blank for the years to Mar 2024 and Mar 2025: the cash-flow statement states money raised on equity instruments other than shares, and with no share capital on record before the period nothing shows whether shares were issued for it, so the figure is not given.

Per share

Standalone, ₹ per share, years to March.

₹ per shareMar 2017Mar 2018Mar 2019Mar 2020Filed 11 AugMar 2021Filed 6 JulMar 2022Filed 28 JunMar 2023Mar 2024Filed 9 JulMar 2025Filed 2 AugMar 2026Filed 30 May
Earnings per share₹3.25₹2.64₹2.80₹2.48₹2.79₹2.72–₹1.84₹1.42₹1.39
Diluted earnings per share–₹2.64₹2.80₹2.48₹2.79₹2.72–₹1.84₹1.42₹1.39
Book value per share–––₹39.49–₹44.77–₹47.33₹48.84₹52.86
Shareholder yield–––––−7.8%–––0.0%
Market cap at the year end (₹ crore)179108683154105–11195144
Shareholder yield is left blank for the years to Mar 2024 and Mar 2025: the cash-flow statement states money raised on equity instruments other than shares, and with no share capital on record before the period nothing shows whether shares were issued for it, so the figure is not given.
RatioMar 2017Mar 2018Mar 2019Mar 2020Filed 11 AugMar 2021Filed 6 JulMar 2022Filed 28 JunMar 2023Mar 2024Filed 9 JulMar 2025Filed 2 AugMar 2026Filed 30 May
Revenue growth–−11.8%1.5%−15.4%–41.4%––19.8%−0.4%
Operating profit growth–−20.3%3.8%−59.4%–142.9%––−34.9%147.4%
Net profit growth–5.0%5.9%−11.4%12.4%15.6%––−14.1%−1.4%
Earnings per share growth–−18.8%6.1%−11.4%12.5%−2.5%––−22.8%−2.1%
–––6.3%–6.6%–3.5%3.0%2.7%
––––––––−0.6 pts−0.2 pts
From the net margin––––––––−1.0 pts0.0 pts
From asset turnover––––––––0.6 pts0.0 pts
From borrowing––––––––−0.1 pts−0.2 pts
Return on capital employed–––2.1%–7.3%–1.7%0.6%2.2%
Cash conversion––––127.4%247.0%–168.5%256.0%255.6%
Interest cover2.13.73.11.31.54.6–0.60.20.9
Debt to equity–––0.19–0.12–0.240.250.33
Receivable days–––117–101–0103100
Inventory days–––21–11–333633
Payable days–––98–0–1238166
Cash conversion cycle, days–––41–112–−905868
Working capital days–––120–149–−40114128
Asset turnover–––1.55–2.01–1.301.591.61
Assets per rupee of net worth–––2.10–2.16–2.302.202.03
Sales per rupee of plant–––24.40–34.06–26.9929.2218.32
Capital spending to depreciation–––––1.11–0.002.684.35
Plant being built, % of plant in use–––0.0%–0.0%––0.0%0.0%
Revenue growth and operating profit growth are left blank for the year to Mar 2021: between the two periods the company restated its earlier figures, so the two are on different bases and the change is not worked out. No balance sheet is on record for the years to Mar 2017, Mar 2018, Mar 2019 and Mar 2021, so its lines and the ratios worked from it are blank there.

Growth and returns over 3, 5 and 10 years

Standalone: the listed company alone, without its subsidiaries. Each window ends with the year to Mar 2026.

Return on assets, latest year
1.3%
Cash from operations against operating profit
141.4%
Measure10 years5 years3 years
Revenue growth, yearly rate–6.3%–
Profit growth, yearly rate–−9.4%–
Return on equity, average–4.0%3.1%
Return on capital employed, average–2.9%1.5%
Operating margin, average1.6%1.4%1.1%
Net margin, average1.5%1.1%1.0%
Asset turnover, average–1.631.50
Cash conversion cycle, days, average–3712
Interest cover, average2.01.60.6
Debt to equity, average–0.240.27

Where the cash came from and went

Standalone: the listed company alone, without its subsidiaries. ₹ crore, added up over each window, which ends with the year to Mar 2026.

₹ crore3 yearsLatest year
Cash from operations28.310.1
Cash from investing−25.7−12.4
Cash from financing1.82.2
Capital spending17.612.4
Dividends paid0.00.0
Shares bought back0.00.0
Shares issued for cash–0.0
Borrowings raised–0.0
Borrowings repaid1.50.0

Accounting checks

Standalone, years to March. Published tests of whether reported profit is backed by cash and the balance sheet.

CheckMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Piotroski score, out of 9Published threshold 3 points out of 9–––––––––9
Altman Z-scorePublished threshold 1.81–––2.88–4.07–2.033.143.34
Beneish M-scorePublished threshold −1.78–––––––––−2.93
Profit not backed by cash, % of assetsPublished threshold 10 per cent of average total assets––––––––−0.112.12
Cash from operations to profit, 3 yearsPublished threshold 0.7 times–––––––––2.24
Receivables growth less revenue growthOur threshold 0 percentage points–––––––––−2.50
Inventory growth less cost-of-goods growthOur threshold 0 percentage points––––––––10.17−7.04
Other current assets growth less revenue growthOur threshold 5 per cent of revenue––––––––1.962.99
Assets under construction, years of additionsOur threshold 2 years of additions––––––––0.000.00
Effective tax ratePublished threshold 17.16 per cent26.2724.5827.2020.0021.5324.92–12.3434.0526.72
Tax charged less tax paid, % of profitOur threshold 10 percentage points–––––−10.88–−0.122.78−2.69
A threshold marked as ours has no published figure; it is the line we read the check against.

Credit ratings

An agency's view of the chance the company repays a borrowing on time, from AAA, the highest, down to D, in default.

DateAgencyBorrowing ratedRatingOutlookAmount, ₹ Cr
27 May 2026Acuite Ratings & Research Limited (opens in a new tab)Bank Loan RatingACUITE BB+Review, Downgrade54.44
27 May 2026Acuite Ratings & Research Limited (opens in a new tab)Bank Loan RatingACUITE A4+Review, Downgrade11.50
26 Aug 2025ICRA Limited (opens in a new tab)Non Fund Based-Others[ICRA]A4 ISSUER NOT COOPERATINGReview, Other15
26 Aug 2025ICRA Limited (opens in a new tab)Fund Based-Cash Credit[ICRA]B+ ISSUER NOT COOPERATINGReview, OtherStable30
The latest rating on each borrowing. The agency's name opens its reasoning for the rating.